VAXART BIOSCIENCES INC
SOUTH SAN FRANCISCO, CALIFORNIA 940806102
$9.27M
Total Contract Value
3 awards
First Award
Jan 12, 2024
Last Award
Jul 12, 2024
Business Size
small
CAGE Code
4GQK7
Top Industries (NAICS)
| NAICS Code | Obligations | Awards |
|---|---|---|
| 541714 | $9.27M | 3 |
Contract Awards
1 awards found
75A50124C00002
Department of Health and Human Services
$9.27M
Jan 12, 2024
CLINICAL TRIAL PLANNING ACTIVITIES FOR A PHASE 2B CLINICAL TRIAL THAT COMPARES VAXART'S XBB VACCINE CANDIDATE TO AN MRNA COMPARATOR TO EVALUATE EFFICACY FOR SYMPTOMATIC AND ASYMPTOMATIC DISEASE, SYSTEMIC AND MUCOSAL IMMUNE INDUCTION, AND ADVERSE
NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2024
Business Details
- UEI
- WS6UMD1QTBC9
- CAGE Code
- 4GQK7
- Address
- 170 HARBOR WAY
STE 300
SOUTH SAN FRANCISCO, CA 940806102 - Congressional District
- CA-15
- Phone
- 6505503500
Parent Company
VAXART BIOSCIENCES INC
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov